Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Invasive growth is triggered by specific signals
- Invasive growth is a response to scatter factors
- Invasive growth is a response to semaphorins
- Invasive growth receptors
- The "receptosome"
- Invasive growth signaling
- Specificity of signal transduction for invasive growth
- The Met "transcriptome"
- Gene expression profiling with microarrays
- HGF regulated genes
- Invasion and metastasis
- Inappropriate activation of MET oncogene
- Hypoxia regulates MET transcription
- HRE and AP-1 site in MET transcription
- Hypoxia controls MET expression at transcription
- MET is overexpressed in hypoxic areas of tumors
- Invasive growth as an escape mechanism
- Invasive growth is driven by hemostatic genes
- Somatic vs. germline oncogene delivery
- MET induces liver pre-neoplastic nodules
- MET transduction causes thrombohemorrhage
- MET causes liver cancer and DIC syndrome
- Thrombohemorrhage precedes cancer onset
- Trousseau's syndrome
- Expression profiling of transduced MLP-30
- Expression profiling of transduced hepatocytes
- MET affects PAI-1 expression
- MET affects Cox-2 expression
- The hypothesis
- Preventing invasive growth
- Decoy Met
- Decoy inactivates HGF receptors
- Delivering HGF-antagonists to tumors
- Systemic delivery of HA
- Parameters of mice transduced with decoy MET
- Decoy MET inhibits tumor growth and metastasis
- Anti-MET Mab inhibits tumor growth and metastasis
- Summary
- Credits
- Thanks
Topics Covered
- Trigger of invasive growth by specific signals
- Invasive growth receptors
- The "receptosome"
- Dynamics of invasive growth signalling
- The MET transcriptome
- HGF regulated genes
- Hypoxia regulates MET transcription
- The effector machinery of invasive growth: the coagulation cascade
- HGF antagonists impair tumor growth and metastasis: a gene therapy strategy
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Comoglio, P. (2007, October 1). The HGF receptor, a targettable regulator of invasive growth [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 23, 2024, from https://doi.org/10.69645/EUWX3306.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Paolo Comoglio has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.